Rahul Argula

机构：Triangle, United Therapeutics (United States) · ORCID：0000-0002-6184-4093

发表论文 53 篇 · 总被引 1539 次 · h-index 17

代表论文

• Inhaled treprostinil in pulmonary hypertension associated with COPD: PERFECT study results (2024 · European Respiratory Journal · 被引 72)
• Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study (2023 · European Respiratory Journal · 被引 71)
• Inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease with less severe haemodynamics: a post hoc analysis of the INCREASE study (2024 · BMJ Open Respiratory Research · 被引 26)
• Tyvaso DPI: Drug-device characteristics and patient clinical considerations (2023 · Pulmonary Pharmacology & Therapeutics · 被引 17)
• Pericardial effusions and sotatercept therapy in pulmonary arterial hypertension: a multicentre, real-world experience (2025 · European Respiratory Journal · 被引 11)
• Treatment With Oral or Inhaled Treprostinil in Patients With Pulmonary Arterial Hypertension and Cardiovascular Comorbidities (2024 · CHEST Journal · 被引 11)